Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma's Medical Liaisons: From KOLs To Outcomes And Virtual Options

Executive Summary

Compliance issues, boundaries of off-label discussions and an enhanced emphasis on patient health outcomes are shaping how medical science liaisons (MSLs) engage with existing and emerging stakeholders. Scrip spoke to senior executives from UCB, GlaxoSmithKline, Novartis and Indegene, a healthcare solutions provider, among others, on the evolving role of MSLs and the potential value of hybrid models in this environment.

You may also be interested in...

Bayer Execs On Digital Acceleration, Getting The Building Blocks Right

Senior executives from Bayer outlined at a recent summit the contours of digital transformation already underway and the vital components of a successful digital team. Firms need to be able to operate technology at the “speed of business” and not “at the speed of a ticketing queue.”

Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes

Manufacturer communications with providers and payers could include real-world evidence and pharmacoeconomic information, associations urge.

Consumer-Focused Off-Label Promotion Seems Possible After Amarin Settlement

Legal agreement with FDA allowing communication about off-label Vascepa use is not limited by audience, speaker or setting, attorneys say.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts